The expert webinar focused on the uromodulin biomarker and introduced its biological functions, diagnostic value and its role in the early detection of kidney damage. The program also included an overview of available clinical data and practical case studies from routine practice.
The webinar was developed in collaboration with specialists from the University Hospital Olomouc, who have long been involved in the research and clinical use of parameter.
Uromodulin has proven to be a reliable parameter for differentiating patients according to the severity of chronic kidney disease (CKD). It enables early identification of kidney function loss and may serve as a complementary biomarker for more accurate assessment of renal function without relying on equation-based estimations.
